Skip to main content
. 2024 Apr 18;11:1393014. doi: 10.3389/fnut.2024.1393014

Figure 4.

Figure 4

Fifty-two-week-old EtOH-fed male mice after fecal microbiota transplantation (FMT) display a protection against liver damage and lipid accumulation. (A) H&E staining of liver of 52-week-old female, male, and male + FMT mice after EtOH oral gavage. (B) Serum levels of markers of liver damage, aspartate aminotransferase (AST) and (C) alanine aminotransferase (ALT), in 52 weeks-old female, male, and male + FMT mice after EtOH (6 g/kg) oral gavage. (D) ORO staining in liver cryosections of female, male, and male + FMT mice after EtOH gavage and (E) each quantification. (F) Quantification of triglyceride content in liver (mg TG/mg liver) of 52-week-old female, male, and male + FMT mice after an EtOH oral gavage. (G) Serum triglycerides (mg/dL) (n = 4–11). Scale bars: 100 μm. *P < 0.05, **P < 0.01, ***P < 0.001. ns, no statistical difference.